Ventures | Harvard Innovation Labs

Ventures

Browse a selection of current and former i-lab ventures.

Ventures

Lab

School

Program

Term

Industry

Clear all filters

AbscoTx

AbscoTx injects image-guided therapy into tumors to educate the immune system to fight cancer locally and at metastatic sites.
Alvus Health INC

Alvus Health is developing a data-centric and automatic platform for target identification and drug discovery.
Aperture Bio

Realizing orders-of-magnitude improvements in speed and sensitivity, Aperture rapidly analyzes proteins in whole cells to map immune interactions.
BioDevek

Improving clinical outcomes following internal surgeries using degradable biomaterials.
Breaking

Breaking Inc. is using synthetic biology to get rid of plastic waste.
CartaBio Inc

A single-cell precision medicine techbio that uses proprietary spatial biology and AI to decode novel disease biology.
Cellforma

Developing life-saving, first-of-its-kind regenerative cell therapies to overcome the unmet need for donor lungs.
Concerto Biosciences

Discovering microbial ensembles for health via a patented screening platform.
Day Zero Diagnostics

Developing technologies to help control healthcare-associated infections (HAIs), where antibiotic resistant organisms can be especially dangerous.
GC Therapeutics

Using synthetic biology to program stem cells into any cell type with best-in-class efficiency, speed, and scalability.
Ilios Therapeutics

Combating neurodegenerative diseases through rationally-designed multi-functional small molecules.
InGel Therapeutics

Regenerative cell-therapy biotech aiming to treat people affected by blindness.
Kern Systems

Kern Systems is developing cheaper and faster DNA synthesis.
Kestrel Therapeutics

Discovering and developing new molecules to treat intractable cancers.
Kinnos

Adding color to disinfectants, visualizing surface coverage for more effective and efficient cleaning in healthcare settings.
KiraGen Bio

Harnessing the power of AI-driven combinatorial gene editing to unlock the full potential of solid tumor CAR-T therapies.
Kiwi Biosciences

Creating the first enzyme solution addressing FODMAPs, a family of hard-to-digest carbohydrates and notorious symptom triggers for those with sensitive guts.
Lightning Biotherapeutics

Sparking immune regeneration by harnessing the body’s inherent regenerative capacity to create novel therapeutics.
Lime Therapeutics

Creating a new class of therapies targeting lipid metabolism in cancers and neurodegenerative disorders.
Manifold Bio

Designing tissue-specific medicines in living systems from the start by combining high-throughput in-vivo studies with AI-guided protein design.
Modulate Bio

Developing therapies to treat neurological disorders, including Essential Tremor, epilepsy, and anxiety.
Nucyrna Therapeutics

Nucyrna Therapeutics aims to redefine RNA-targeting therapeutics, starting in neurodegenerative diseases.
Overture Therapeutics

Creating better, healthier weight-loss intervention therapies for treating obesity and its co-morbidities by targeting emerging biological pathways.
PathCision Medicine, Inc.

Transforming tissue pathology insights into targeted therapies for complex diseases.
Promakhos Therapeutics

Developing oral, non-immunosuppressive, small molecules to cure chronic inflammatory disorders.
Revision Bio

Creating next-generation precision genome editing technologies.
Stratagen Bio

Transforming MRI scans into a tool for objective clinical decision-making and quantitative biomarker assessment.
Tectonic Therapeutic, Inc.

Transforming the discovery of novel drugs addressing targets in the GPCR family.
TetraScience

Developing the world's only data and AI cloud built for science.
Transcera

Transforming chronic disease treatment through improved biologic drug delivery.
Veri Nano

A bionanotechnology company developing antimicrobial materials and nanoparticle delivery systems for human and animal health.